冒号 发表于 2025-3-28 16:05:18

http://reply.papertrans.cn/23/2283/228265/228265_41.png

慢跑 发表于 2025-3-28 18:49:22

http://reply.papertrans.cn/23/2283/228265/228265_42.png

抱狗不敢前 发表于 2025-3-29 02:24:24

http://reply.papertrans.cn/23/2283/228265/228265_43.png

Pathogen 发表于 2025-3-29 04:00:46

http://reply.papertrans.cn/23/2283/228265/228265_44.png

Lineage 发表于 2025-3-29 10:58:08

http://reply.papertrans.cn/23/2283/228265/228265_45.png

配置 发表于 2025-3-29 13:19:30

http://reply.papertrans.cn/23/2283/228265/228265_46.png

Interregnum 发表于 2025-3-29 16:29:36

https://doi.org/10.1007/978-1-84628-587-5Clinical Trials; Instrument; Methodology; Study; bone; clinical trial; drug; osteoporosis; research

Encoding 发表于 2025-3-29 22:30:33

978-1-84628-389-5Springer-Verlag London 2007

全面 发表于 2025-3-30 00:49:24

Discussion and Future Subsidence Monitoring,ve a book of their own? There are three main reasons. First, most diseases have a well-understood definition and aetiology. Osteoporosis is a disease that is understood by those working within the subspecialty, but currently there is no definition that is agreeable to both medical and scientific com

epidermis 发表于 2025-3-30 06:55:01

Discussion and Future Subsidence Monitoring,here has not been a clear hypothesis, endpoints are inappropriate, and the study design is inadequate, it is unlikely that the outcome of the study will be used to contribute to the process of regulatory approval, or form part of a metaanalysis. It is important to get the design right from the start
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Clinical Trials in Osteoporosis; Derek Pearson (Joint Service Manager),Colin G. Mil Book 2007Latest edition Springer-Verlag London 2007 Cl